The largest youth competition in Brazil, the Copa São Paulo de Futebol Júnior, kicks off this Friday (2). The 2026 edition arrives with a mix of renewal and an absence that caught many fans by ...

Unlike traditional GLP-1 therapies, which often cause muscle loss alongside fat reduction, WVE-007 achieved a 9.4% reduction ...

The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

The MG Nemo is a very underrated kit. Despite being an older model (circa 2006), it’s an excellent build with a unique look ...

Verastem, Inc. shifts focus to VS-7375 for KRAS G12D tumors after ending RAMP-203. Click to learn about VSTM's key catalysts ...

Tirzepatide is noninferior to dulaglutide with respect to a composite of death from cardiovascular (CV) causes, myocardial ...

Once-weekly subcutaneous semaglutide 2.4 mg reduced the risk for any hospitalization among adults with obesity and ...

Set six years after Big Boss’ climactic battle with his former mentor, Metal Gear Solid: Portable Ops picks up the legendary ...

Curious to know which obesity stories grabbed the attention of readers this year? Medscape Medical News develops a list of ...

Jonathan Strober, MD, discusses promising results from the VIBRANCE-MG trial, highlighting nipocalimab's safety and efficacy for pediatric myasthenia gravis.

Novo Nordisk A/S secures FDA nod for oral Wegovy, expanding obesity treatment options. Click for how oral GLP-1 therapies ...

Fluoride remains the cornerstone of preventive dentistry, and researchers have analyzed the many delivery methods of fluoride ...